This company listing is no longer active
American Healthcare REIT Valuation
Is AHTR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of AHTR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: AHTR ($10.96) is trading below our estimate of fair value ($20.23)
Significantly Below Fair Value: AHTR is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for AHTR?
Other financial metrics that can be useful for relative valuation.
What is AHTR's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.84b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 2.2x |
Enterprise Value/EBITDA | 14.1x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does AHTR's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 7.8x | ||
LTC LTC Properties | 8x | 4.3% | US$1.6b |
SILA Sila Realty Trust | 7.2x | 10.8% | US$1.4b |
SBRA Sabra Health Care REIT | 5.8x | 5.2% | US$3.7b |
NHI National Health Investors | 10.1x | 16.2% | US$3.2b |
AHTR American Healthcare REIT | 1.1x | 8.6% | US$1.8b |
Price-To-Sales vs Peers: AHTR is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (7.8x).
Price to Earnings Ratio vs Industry
How does AHTR's PE Ratio compare vs other companies in the US Health Care REITs Industry?
Price-To-Sales vs Industry: AHTR is good value based on its Price-To-Sales Ratio (1.1x) compared to the US Health Care REITs industry average (5.4x).
Price to Sales Ratio vs Fair Ratio
What is AHTR's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.1x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate AHTR's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.